Skip to content

Clinical trials

Phase 1/2 Hypertension trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 1/2 Country / region: United States Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20061
20081
20093
20101
20111
20122
20133
20153
20163
20172
20182
20201
20212
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting5
Terminated5
Withdrawn5
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Florida State University3
University of Texas Southwestern Medical Center2
Vanderbilt University Medical Center2
ARKAY Therapeutics1
CRISPR Therapeutics AG1
Cedars-Sinai Medical Center1
Colorado State University1
Emory University1
John C Burnett1
Lacy Alexander1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension34
Obesity7
Cardiovascular Diseases6
Inflammation3
Diabetes Mellitus2
Diabetes Mellitus, Type 22
Essential Hypertension2
Hyperlipidemias2
Metabolic Syndrome2
Prehypertension2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.